Black Diamond Therapeutics (BDTX)
$2.87
Black Diamond Therapeutics (BDTX) Share Price Forecast
Currently 12 wall-street analysts regularly analyze the financials of Black Diamond Therapeutics on a frequent basis to provide recommendations along with target share price. 12 analysts offering 12-month price forecasts for Black Diamond Therapeutics (BDTX) have a share price target of $11.33. This median of share price forecast represents a 294.77% upside from the latest price of $2.87 as on 30.09.23.
Black Diamond Therapeutics (BDTX) Price vs Consensus Price Target
Price
Target Price
As per the chart shown above, analysts believe that the Black Diamond Therapeutics (BDTX) share price will touch around $11.33 in next 12-months.
Black Diamond Therapeutics (BDTX) Share Price Forecast v/s Share Price Today
Below is a chart showing the percentage difference between Black Diamond Therapeutics's share price and its median forecast price. As on 30.09.23, the difference is -68.58%
Black Diamond Therapeutics (BDTX): Difference between Current Price & Median Forecasted Price
Difference in Percentage terms
Black Diamond Therapeutics (BDTX) Share Price : Analyst Recommendation
Based on 12 analysts tracking and researching Black Diamond Therapeutics (BDTX) share have buy recommendation on an average.
| 3M Ago | 1M Ago | Current | |
| Buy | 5 | 5 | 6 |
| Outperform | 3 | 2 | 5 |
| Hold | 4 | 4 | 1 |
| Underperform | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 |
Black Diamond Therapeutics (BDTX) Share Price Technical Analysis
50 Day Moving Average v/s Current Share Price
Moving Average
Price
200 Day Moving Average v/s Current Share Price
Moving Average
Price
FAQs
The latest share price target for Black Diamond Therapeutics (BDTX) is $11.33, offered by 12 analysts offering 12-month price forecasts.
Black Diamond Therapeutics (BDTX) has a maximum of 2.95 upside potential, based on 12 analysts offering 12-month price forecasts.
Based on 12 analysts tracking and researching Black Diamond Therapeutics (BDTX), 91.67% have a buy recommendation. Remaining 8.33% have either sell or hold recommendations.
The latest share price of Black Diamond Therapeutics (BDTX) is $2.87 as of 30/09/2023.
11 of total 12 analysts offering stock ratings for Black Diamond Therapeutics BDTX have recommended buy rating.
₹0 US Stocks a/c Opening Fee